Prezzo Delle Azioni
118.70
Cambio Giornaliero
1.82 1.56%
Mensile
9.40%
Annuale
20.41%
Q1 Previsione
111.83




Ebit Cambiamento Data
AbbVie USD 1.45B 4.26B 2025-09
Alcon AG USD 334M 84M 2025-09
Almirall EUR 43.02M 28.78M 2025-06
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD -1.5B 5.01B 2025-09
Autolus Therapeutics Ltd USD -82.61M 17.37M 2025-06
Bayer EUR -399M 363M 2025-09
Biogen USD 659.6M 157M 2025-09
Bristol-Myers Squibb USD 4.04B 1.78B 2025-09
Eli Lilly USD 7.41B 391.2M 2025-09
Fresenius EUR 574M 14M 2025-09
Fresenius Medical Care EUR 449.94M 18.94M 2025-09
Galapagos EUR -41.67M 15.35M 2025-09
Genmab DKK 432M 900.27M 2025-06
Gilead Sciences USD 3.51B 810M 2025-09
GlaxoSmithKline GBP 2.79B 716M 2025-09
GRIFOLS EUR 352.11M 20.18M 2025-09
Hikma Pharmaceutical USD 317M 85M 2024-12
J&J USD 5.11B 2.3B 2025-12
Lonza CHF 673M 54M 2025-06
Merck EUR 1.21B 180M 2025-09
Merck USD 6.24B 1.32B 2025-12
Novartis USD -9.19B 13.87B 2025-06
Novartis USD 4.48B 343M 2025-09
Novo Nordisk DKK 32.38B 1.7B 2025-12
Orion EUR 104.6M 26.7M 2025-06
Pfizer USD 4.65B 71M 2025-12
Philips EUR 329M 159M 2025-09
Recordati EUR 165.64M 21.71M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
UCB EUR 502M 168M 2024-12


Novartis - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.